Synmosa Biopharma Corporation (TPEX:4114)

Synmosa Biopharma Revenue

Synmosa Biopharma had revenue of 1.42B TWD in the quarter ending September 30, 2024, with 15.35% growth. This brings the company's revenue in the last twelve months to 5.38B, up 6.24% year-over-year. In the year 2023, Synmosa Biopharma had annual revenue of 5.14B with 17.19% growth.

• Revenue (ttm): 5.38B
• Revenue Growth: +6.24%
• P/S Ratio: 2.57
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 13.83B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.14B	754.13M	17.19%
Dec 31, 2022	4.39B	1.15B	35.59%
Dec 31, 2021	3.23B	196.67M	6.47%
Dec 31, 2020	3.04B	358.32M	13.37%
Dec 31, 2019	2.68B	316.77M	13.40%